Cue Biopharma CUE
NASDAQ CUE
$18.89 -0.06 (-0.32%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cue Biopharma (CUE) Non Operating Interest Expenses (2022)

Updated

Cue Biopharma's Non Operating Interest Expenses came in at $124,000 for Q3 2022, down 39.8% from the prior quarter.

Analysis

Cue Biopharma (CUE) Non Operating Interest Expenses (2022) Analysis & Trends

Over the trailing twelve months to Sep 30, 2022, Cue Biopharma reported Non Operating Interest Expenses of $355,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Cue Biopharma 119.17 Mn 28.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 124,000.00
Jun 30, 2022 206,000.00
Mar 31, 2022 25,000.00
API Access

Cue Biopharma Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CUE&period=max&api_key=YOUR_API_KEY